Abstract. The aim of the present study was to investigate the clinical value of the preoperative neutrophil-to-lymphocyte ratio (NLR) and red blood cell distribution width (RDW) in the peripheral blood of colorectal carcinoma (CRC) patients. Clinical data obtained from 240 patients with CRC undergoing radical surgical resection in Shandong Provincial Hospital Affiliated to Shandong University (Jinan, Shandong, China) between January 2011 and April 2015 were retrospectively analyzed. Data were also collected from 110 patients with colon polyps and 48 healthy volunteers to serve as controls for comparative analysis. The clinicopathological characteristics of the patients in the low and high NLR and RDW groups were compared. The NLR and RDW values were compared prior to and following surgery. Kaplan-Meier analyses and Cox regression modeling were performed to predict overall survival (OS) and disease-free survival (DFS). The NLR and RDW levels in the CRC patients were markedly higher than those in the colon polyp patients and the healthy controls. The optimum NLR and RDW cutoff points for CRC were 2.06 and 13.45%, respectively. Significant differences were detected in tumor location, diameter, degree of differentiation, tumor depth, carcinoembryonic antigen and carbohydrate antigen 199 when comparing the high and low NLR groups (P<0.05). A high RDW was significantly associated with distant metastasis and older age in CRC patients. No significant difference was detected in the NLR and RDW levels of CRC patients prior to and following surgery (P>0.05). CRC patients with an increased RDW had significantly worse OS and DFS rates, particularly those with metastatic CRC (P<0.05). Patients with a high NLR exhibited a reduced DFS time in CRC (P=0.053), although this difference was not significant, and a significantly worse DFS time in metastatic CRC (P=0.047). In conclusion, it is convenient to use preoperative NLR and RDW to predict prognosis following surgery for patients with CRC.
Introduction
Colorectal cancer (CRC) is one of the major causes of cancer-associated mortality and one of the most curable gastrointestinal cancers (1) . It is therefore important to identify all the factors that may serve a role in the diagnosis and prognosis estimation of CRC such that timely diagnosis and treatment decisions may be made. A previous study demonstrated that the number of CRC patients may be reduced through routine screening (2) , but the rates of screening for CRC remain low (2) (3) (4) .
Cancer causes under-nutrition and chronic inflammation, and cancer-related inflammation has been reported to be a crucial factor in cancer progression and cancer-associated survival (5, 6) . In addition to the pathological characteristics of cancer, other non-cancer factors, including general health condition, may determine the outcomes of patients with cancer (7) . The neutrophil-to-lymphocyte ratio (NLR) has been used as an indicator of the inflammatory-related response (8) . The NLR is equivalent to the number of neutrophils divided by the number of lymphocytes. An elevated NLR has been reported to be a valuable predictive indicator of various cancer types, including epithelial ovarian, pancreatic, gastric and breast cancer (9) (10) (11) (12) . The red cell distribution width (RDW) is also a generally used laboratory indicator of inflammatory response (13) . The RDW reflects the variation in erythrocyte size, and an increased RDW indicates anisocytosis (14) . Previous studies have also demonstrated the role of an increased RDW, which predicts a worse overall survival (OS) rate and an increased disease-specific mortality rate in patients with chronic inflammatory diseases and certain cancer types (15) (16) (17) (18) (19) , in addition to promoting the progression of cardiovascular and cerebrovascular diseases (20) (21) (22) . However, few specific studies regarding the predictive value of NLR and RDW in patients with CRC have been reported (23, 24) . The present study systematically evaluated whether NLR and RDW elevations may serve potential roles as biomarkers of CRC activity. Any associations between the NLR or RDW and histopathological parameters in patients with CRC were identified, any differences in NLR and RDW prior to and following radical surgical resection were determined, and the prognostic importance of NLR and RDW in CRC patients was subsequently evaluated.
Materials and methods
Patients. Clinical data from 240 patients with CRC who had undergone radical surgical resection at Shandong Provincial Hospital Affiliated to Shandong University (Shandong, China) between January 2011 and April 2015 were analyzed retrospectively. Data from 110 patients with colon polyps and 48 healthy volunteers were also collected to serve as controls for comparative analysis. Following radical resection, patients were histopathologically diagnosed by two pathologists. Patients with CRC were enrolled according to the following inclusive criteria: CRC diagnosed by histopathology (the invasion of the mucosal muscle layer by cancer cells), radical resection under a microscope, blood parameters, and clinicopathological and follow-up results. Patients with anemia, hematological disorders, active infectious diseases, venous thrombosis diagnosed within the last 6 months, a history of blood transfusion within the last 3 months, a treatment history of asiderosis, hypertension, cardiac failure, autoimmune disorders and a history of other malignancies were excluded from the study. Blood parameters were detected within 1 week prior to surgery and 3 weeks after surgery. The complete blood count (including NLR and RDW) was detected using a hematology analyzer XE-2100 (Sysmex Corporation, Kobe, Japan). Tumor markers [carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9)] were measured within 1 month prior to surgery. CEA and CA19-9 were analyzed using a Cobas e601 analyzer (Roche Diagnostics GmbH, Mannheim, Germany). The high and low values of NLR or RDW were compared in terms of the CRC location, tumor diameter, Tumor-Node-Metastasis (TNM) stage (25) , degree of differentiation, sex, age and tumor markers, as well as changes in the NLR and RDW prior to and following radical surgical resection. A total of 128 patients, including 54 patients with metastatic CRC, were followed up regularly through telephone interviews and patients received their last follow-up in June 2016. The first research end-point was OS time, which was defined as the time from the date of surgery to mortality from any cause. The second study end-point was disease-free survival (DFS) time, which was defined as the time from the date of surgery to the date of identification of disease recurrence, either radiological or histological. This study was approved by the Ethics Committee of the Shandong Provincial Hospital Affiliated to Shandong University. Written informed consent was obtained from all participants. 
Results
Comparison between groups in terms of the RDW and NLR values. The mean ± SD of the NLR in the CRC, colon polyps and healthy control groups was 2.81±2.60, 1.99±0.94 and 1.68±0.48, respectively. The NLR in the CRC patients was significantly higher compared with that in the colon polyps patients and the healthy controls (P=0.001 and P=0.001, respectively). The colon polyps group demonstrated no significant difference in NLR compared with the healthy control group (P=0.390) (Fig. 1A) . The mean ± SD of RDW in the CRC, colon polyps and healthy control groups were 13.51±1.74, 13.02±0.81 and 12.82±0.47%, respectively. The RDW in the CRC group was increased significantly compared with that of the colon polyps and the healthy control groups (P=0.003 and P=0.002, respectively). No significant difference in RDW was observed between the colon polyps patients and the healthy controls (P=0.430) (Fig. 1B) .
Association between NLR or RDW and clinicopathological characteristics. The area under the curve of the NLR was 0.642 [95% confidence interval (CI), 0.582-0.703; P<0.001], and that of the RDW was 0.601 (95% CI, 0.539-0.663; P<0.001) (Fig. 2) . When the YI was at its maximum (YI=0.256), the NLR was 2.06, the sensitivity was 58.3% and the specificity was 67.3%, revealing that the optimal cutoff value for NLR was 2.06. Thus, patients with CRC were divided into high NLR (≥2.06) and low NLR (<2.06) groups. When the RDW was 13.45%, the sensitivity was 38.8%, the specificity was 80.9% and the YI was at its maximum (YI=0.197). The patients with CRC were then divided into high RDW (≥13.45%) and low RDW (<13.45%) groups. The clinicopathological characteristics of the 2 groups were compared in terms of the NLR and the RDW (Table I) . The high NLR group was associated with tumor location (colon), a larger tumor diameter, poor tumor differentiation, deeper tumor infiltration, and high CEA and CA19-9 levels (P<0.05). A high RDW was revealed to be associated with older age and distant metastases (P<0.05). The clinicopathological factors that likely caused the increased NLR and RDW were also evaluated following evaluation of other factors using logistic regression analysis. The results demonstrated that a larger tumor diameter and poor tumor differentiation were independent risk factors for increased NLR (P<0.05), while older age and distant metastases were independent risk factors for increased RDW (P<0.05) (Table II) .
Differences in the NLR and RDW prior to and following surgery. Differences in the NLR and RDW prior to and following surgery were analyzed in 45 patients with CRC. The median (interquartile range) values of the NLR and RDW prior to surgery were 2.20 (1.765-3.025) and 13.7% (12.90-15.85%), respectively, and following surgery were 2.30 (1.500-4.005) and 13.6% (12.85-15.70%), respectively. No significant differences in the NLR or RDW were observed prior to and following surgery (P=0.299 and P=0.955, respectively) (Fig. 3) . Furthermore, the patients were divided into 2 groups according to the change in NLR and RDW values (the value following surgery divided by the value prior to surgery): NLR <1 and ≥1, and RDW <1 and ≥1. The association between the two groups and TNM stage was analyzed. These results demonstrated that no apparent association existed between changes in the NLR or RDW and TNM stage (Table III) .
Survival analysis of prognostic factors.
The median follow-up duration was 40 months (range, 1-65 months). The Kaplan-Meier cumulative survival curves for 128 patients with CRC are presented (Fig. 4) . The mean OS time was 57.3 months in the low RDW group (95% CI, 53.5-61.1) and 46.9 months in the high RDW group (95% CI, 40.3-53.6). In addition, the mean DFS time was 55.1 months in the low RDW group (95% CI, 51.2-59.0) and 45.4 months in the high RDW group (95% CI, 38.8-52.0). The high RDW group exhibited an unfavorable OS time (P=0.025) and a shorter DFS time (P=0.030) compared with the low RDW group (Fig. 4B and D) . With regards to the NLR, the mean OS and DFS times were 57.4 months and 55.7 months, respectively, in the low NLR group (95% CI, 52.8-62.0 and 50.9-60.4, respectively), and 52.0 months and 49.4 months, respectively, in the high NLR group (95% CI, 46.9-57.1 and 44.3-54.5, respectively). Therefore, the NLR was not significantly associated with OS or DFS (P=0.145 and P=0.053, respectively) ( Fig. 4A and C) . For 54 patients with metastatic CRC, an increased RDW was associated with a significantly shorter OS (P=0.014) and DFS (P=0.005), while an increased NLR was only associated with a significantly shorter DFS (P= 0.047) (Fig. 5) . For 128 patients with CRC, univariate analysis revealed that OS was significantly associated with RDW (P=0.030), degree of differentiation (P<0.001), pStage (P<0.001) (25) , depth of tumor (P=0.028), lymph node metastasis (P<0.001), distant metastasis (P<0.001), CEA (P=0.031) and CA19-9 (P=0.008), while DFS demonstrated a similar association with RDW (Table IV) . For 54 patients with metastatic CRC, univariate analysis revealed that OS was significantly associated with RDW (P=0.019), degree of differentiation (P=0.008), pStage (P=0.012), distant metastasis (P=0.012) and CA19-9 P<0.05 was considered to indicate a statistically significant difference. Total patient numbers vary as pathological data regarding tumor diameter was only available from 204 patients and only 187 patients were examined for tumor markers, CEA and CA19-9. NLR, neutrophil-to-lymphocyte ratio; RDW, red blood cell distribution width; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9.
(P=0.046), while DFS exhibited a similar association with RDW (P=0.007), degree of differentiation (P=0.005), pStage (P=0.014), distant metastasis (P=0.014), CEA (P=0.041) and CA19-9 (P=0.037). The multivariate analyses revealed that RDW, the degree of differentiation and CA19-9 may act as independent prognostic indicators of OS and DFS in patients with metastatic CRC (Table V) .
Discussion
CRC is one of the most common cancers and the fourth highest cause of cancer-associated mortality in the world (26) . In China, with the increasing number of risk factors, including an aging population and changes in dietary habits (e.g., reduced fiber intake), CRC has become the fifth most common cancer in the country (27) . Tumor-associated inflammatory cytokines and mediators may mediate inflammatory responses, which lead to tumor growth, infiltration and metastasis (28) . Previous studies have demonstrated that blood parameters, including C-reactive protein, albumin, hemoglobin, mean corpuscular volume, NLR, white blood cell count and RDW, are significantly associated with the host inflammatory response and the poorer nutritional status induced by numerous types of cancer, partially through acting as predictors of disease progression and prognosis (29) (30) (31) . Firstly, elevated neutrophils facilitate tumor proliferation, migration and vasculogenesis. Secondly, lymphocytes can promote cytotoxic cell activation and cytokine production, which inhibit tumor proliferation and migration. Thus, low lymphocyte levels destroy the antitumor immune response and result in a poorer prognosis. Therefore, NLR reflects the balance between the pro-tumor inflammatory response and the antitumor immune response (32) . Furthermore, several studies have reported that an increased preoperative NLR is associated with the activated inflammatory response, advanced stage and poorer survival in patients with CRC, non-small cell lung cancer and hepatocellular carcinoma (23, (33) (34) (35) . RDW has been used as an early indicator of increased oxidative stress and disorders in iron deficiency anemia and iron mobilization, and its increase is associated with inflammation markers, including C-reactive protein and interleukin-6 (36,37). Despite previous studies that have evaluated the clinical value of RDW as a prognostic indicator in patients with impaired cardiometabolic function and active inflammation, there is limited data available concerning the potential use of RDW as a biomarker of cancer growth and metastatic activity in solid cancer types (20, 36) . A previous study indicated that a high preoperative RDW could be used to predict the long-term survival rate of patients with lung cancer (38) . Another study reported that for patients with symptomatic multiple myeloma, a preoperative increase in RDW may reflect worse progression-free survival (39). Albayrak et al (19) demonstrated that an increased RDW was significantly associated with an elevated risk of progressing into advanced prostate cancer. RDW has been gradually used to predict inflammatory status and tumor stress.
Therefore, in the present study, the clinical value of NLR and RDW in patients with CRC was detected. Karaman et al (40) reported that NLR may be used to distinguish neoplastic from non-neoplastic colon polyps, as the NLR was revealed Table II . Logistic regression analysis of NLR-and RDW-associated risk factors. ----------------------------------------------------------------------------------------------------------------------- to be elevated in neoplastic polyps. Ay et al (24) observed that a significantly higher RDW was detected in patients with CRC compared with that in individuals with colon polyps. In the present study, the NLR and RDW values were higher in patients with CRC compared with those in patients with colon polyps and healthy controls, which is consistent with the results of the aforementioned study. At present, the mechanism underlying this effect has not been confirmed. It is generally believed that the onset of CRC begins with an infection or an inflammatory response. NLR and RDW are sensitive indicators that reflect the activation of the inflammatory system and are involved in the inflammatory response (41) . Neutrophils remodel the extracellular matrix to promote tumor growth and invasion, and inhibit lymphocytes from killing the malignant tumor cells (42) . RDW is a sensitive and specific indicator of early iron deficiency and malnutrition in CRC (43) . Therefore, when the NLR and the RDW are elevated in CRC, the body's defense mechanism is weakened and the barrier against malignant cells is destroyed, ultimately leading to a poor survival prognosis. This concept is consistent with the results of the present study.
NLR RDW ---------------------------------------------------------------------------------------------------------------------------
In the present study, the cutoff values for NLR and RDW were determined to be 2.06 and 13.45%, respectively, using the ROC curve. CRC patients with an elevated NLR (NLR ≥2.06) appeared to exhibit more clinicopathological characteristics associated with advanced conditions, including a larger tumor diameter, poor tumor differentiation, deeper tumor infiltration, and high CEA and CA19-9 levels (P<0.05). A higher RDW was also detected in patients with clinicopathological features associated with advanced conditions, including older age and distant metastasis (P<0.05). Furthermore, the logistic regression analysis revealed that a larger tumor diameter and poor tumor differentiation were independent risk factors associated with an increased 
Change in NLR
Change NLR, neutrophil-to-lymphocyte ratio; RDW, red blood cell distribution width; TNM, Tumor-Node-Metastasis. Univariate analysis was performed using the Kaplan-Meier analysis model and the log-rank test and values of P<0.05 in the univariate analysis were entered into a multivariate analysis, which was performed using the Cox proportional hazards models with the forward likelihood method. OS, overall survival; DFS, disease-free survival; HR, hazard ratio; CI, confidence interval; NLR, neutrophil-to-lymphocyte ratio; RDW, red blood cell distribution width; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9. Univariate analysis was performed using the Kaplan-Meier analysis model and the log-rank test and values of P<0.05 in the univariate analysis were entered into a multivariate analysis, which was performed using the Cox proportional hazards models with the forward likelihood method. OS, overall survival; DFS, disease-free survival; HR, hazard ratio; CI, confidence interval; NLR, neutrophil-to-lymphocyte ratio; RDW, red blood cell distribution width; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9.
NLR (P<0.05), while older age and distant metastases were independent risk factors associated with an increased RDW (P<0.05). Few studies have compared the changes in the NLR and RDW prior to and following surgery; however, no significant difference was observed and there was no apparent association between the changes in the NLR and RDW and TNM stage in the present study.
The Kaplan-Meier cumulative survival rates for OS and DFS demonstrated that a high RDW value indicated significantly shorter OS and DFS times in the 128 CRC patients and in the 54 patients with metastases. The high NLR group had no association with OS or DFS in the 128 patients with CRC. Furthermore, an increased NLR was indicative of a significantly shorter DFS time for the 54 patients with metastatic CRC. These results revealed that RDW serves an important role in predicting the survival of patients with CRC, particularly those with metastatic CRC.
Furthermore, univariate and multivariate analyses indicated that, for CRC, only lymph node metastasis and the degree of differentiation were independent prognostic indicators for OS and DFS. The potential use of NLR and RDW as independent prognostic indicators for CRC was not demonstrated in the present study. Patients with metastasis were analyzed separately in order to reduce bias and it was revealed that for metastatic CRC, RDW may act as an independent prognostic indicator for OS and DFS, which has also been confirmed in previous studies. Zou et al (41) reported that the NLR acted as an independent prognostic indicator in patients with CRC. Furthermore, Malietzis et al (44) demonstrated that the preoperative NLR could be an independent prognostic indicator for patients with CRC. Shibutani et al (45) reported that the preoperative NLR was a simple biomarker and indicator of poor prognosis for CRC following surgery. Zhao et al (46) detected that patients with hepatocellular carcinoma exhibiting high preoperative RDW values had significantly poorer survival compared with those with low levels of RDW.
There were a number of limitations to the present study. As is the case for the majority of retrospective studies, there may have been unavoidable errors in the data collection. In addition, the number of subjects in the present study was relatively small and the follow-up duration was not that long. Thus, the findings of this study should be validated in further investigations with larger subject sizes and longer follow-up durations.
Pre-operative NLR and RDW values are simple and conveniently measured biomarkers of clinical diagnosis and prognostic assessment in patients with CRC. NLR and RDW may function as novel indicators that precisely predict the prognosis in patients with CRC, particularly in patients with metastatic CRC.
